PKD1 induces p21waf1 and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2

Cell

Volumn 109, Issue 2, 2002, Pages 157-168

  Bhunia, Anil Kumar ^a   Piontek, Klaus ^a   Boletta, Alessandra ^a   Liu, Lijuan ^a   Qian, Feng ^a   Xu, Pei Ning ^a   Germino, F Joseph ^b   Germino, Gregory G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; JANUS KINASE; JANUS KINASE 1; JANUS KINASE 2; POLYCYSTIN; POLYCYSTIN 1; POLYCYSTIN 2; PROTEIN; PROTEIN P21; STAT1 PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE MUTATION; GROWTH REGULATION; HUMAN; HUMAN CELL; KIDNEY POLYCYSTIC DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION;

ANIMALIA; JANUS;

EID: 0037133954     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(02)00716-X     Document Type: Article

References (54)

1. Induction of epithelial tubules by growth factor HGF depends on the STAT pathway
2. Polycystin-1, the gene product of PKD1, induces resistance to apoptosis and spontaneous tubulogenesis in MDCK cells
3. Epidermal growth factor-induced growth inhibition requires STAT1 activation
4. cip1/waf1 mediated by STAT1
5. STATs and gene regulation
6. cip1/waf1 undergo normal development, but are defective in G1 checkpoint control
7. STAT signaling is active during early mammalian development
8. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease
9. WAF1, a potential mediator of p53 tumor suppression
10. The polycystic kidney disease gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16
11. B-lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transciption (STAT)1 and STAT3 constitutively phosphorylated in serine residues
12. Autosomal dominant polycystic kidney disease
13. 2+-permeable nonselective cation channel
14. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents
15. The JAK-STAT pathway in Drosophila
16. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains
17. Strong homophilic interactions of the Ig-like domains of polycystin-1, the protein product of an autosomal dominant polycystic kidney disease gene, PKD1
18. Stats: Signal transducers and activators of transcription
19. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signaling
20. Expression of differentiation antigens and growth-related genes in normal kidney, autosomal dominant polycystic kidney disease, and renal cell carcinoma
21. Socs: Physiological suppressors of cytokine signaling
22. Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD)
23. Regulation of STAT-dependent pathways by growth factors and cytokines
24. Jaks and STATs: Biological implications
25. Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation
26. Comparison of Pkd1-targeted mutants reveals that loss of polycystin-1 causes cystogenesis and bone defects
27. Transcriptional regulation of the cyclin D1 promoter by STAT5: Its involvement in cytokine-dependent growth of hematopoietic cells
28. P21waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stress-activated kinases
29. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway
30. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein
31. Proliferative activity of cyst epithelium in human renal cystic diseases
32. Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis
33. Jak2 is essential for signaling through a variety of cytokine receptors
34. P53-independent expression of p21Cip1 in muscle and other terminally differentiating cells
35. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I
36. PKD1 interacts with PKD2 through a probable coiled-coil domain
37. Identification of SH2-β as a potent cytoplasmic activator of the tyrosine kinase Janus kinase 2
38. Identification of SH2-Bβ as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling
39. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors
40. FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT1 pathway
41. Cytokine-inducible SH2 protein-3 (CIS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain
42. Transcriptional responses to polypeptide ligands: The JAK-STAT pathway
43. CDK inhibitors: Positive and negative regulators of G1-phase progression
44. A unique glucose-dependent apoptotic pathway induced by c-Myc
45. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality
46. STAM, signal transducing adaptor molecule, is associated with Janus kinases and involved in signaling for cell growth and c-myc induction
47. Systemic manifestations of renal cystic disease
48. Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2
49. Specific association of the gene product of PKD2 with the TRPC1 channel
50. Somatic mutations of PKD1 in ADPKD2 cystic tissue suggests a possible pathogenic effect of trans-heterozygous mutations
51. Apoptosis and loss of renal tissue in polycystic kidney diseases
52. Somatic inactivation of Pkd2 results in polycystic kidney disease
53. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop
54. The Janus kinase family of protein tyrosine kinases and their role in signaling